Skip to main content
Journal cover image

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.

Publication ,  Journal Article
Kato, ET; Morrow, DA; Guo, J; Berg, DD; Blazing, MA; Bohula, EA; Bonaca, MP; Cannon, CP; de Lemos, JA; Giugliano, RP; Jarolim, P; Kempf, T ...
Published in: Eur Heart J
January 21, 2023

AIMS: Levels of growth differentiation factor 15 (GDF-15), a cytokine secreted in response to cellular stress and inflammation, have been associated with multiple types of cardiovascular (CV) events. However, its comparative prognostic performance across different presentations of atherosclerotic cardiovascular disease (ASCVD) remains unknown. METHODS AND RESULTS: An individual patient meta-analysis was performed using data pooled from eight trials including 53 486 patients. Baseline GDF-15 concentration was analyzed as a continuous variable and using established cutpoints (<1200 ng/L, 1200-1800 ng/L, > 1800 ng/L) to evaluate its prognostic performance for CV death/hospitalization for heart failure (HHF), major adverse cardiovascular events (MACE), and their components using Cox models adjusted for clinical variables and established CV biomarkers. Analyses were further stratified on ASCVD status: acute coronary syndrome (ACS), stabilized after recent ACS, and stable ASCVD. Overall, higher GDF-15 concentration was significantly and independently associated with an increased rate of CV death/HHF and MACE (P < 0.001 for each). However, while GDF-15 showed a robust and consistent independent association with CV death and HHF across all presentations of ASCVD, its prognostic association with future myocardial infarction (MI) and stroke only remained significant in patients stabilized after recent ACS or with stable ASCVD [hazard ratio (HR): 1.24, 95% confidence interval (CI): 1.17-1.31 and HR: 1.16, 95% CI: 1.05-1.28 for MI and stroke, respectively] and not in ACS (HR: 0.98, 95% CI: 0.90-1.06 and HR: 0.87, 95% CI: 0.39-1.92, respectively). CONCLUSION: Growth differentiation factor 15 consistently adds prognostic information for CV death and HHF across the spectrum of ASCVD. GDF-15 also adds prognostic information for MI and stroke beyond clinical risk factors and cardiac biomarkers but not in the setting of ACS.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

January 21, 2023

Volume

44

Issue

4

Start / End Page

293 / 300

Location

England

Related Subject Headings

  • Stroke
  • Risk Factors
  • Myocardial Infarction
  • Humans
  • Heart Failure
  • Heart Disease Risk Factors
  • Growth Differentiation Factor 15
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Biomarkers
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kato, E. T., Morrow, D. A., Guo, J., Berg, D. D., Blazing, M. A., Bohula, E. A., … Sabatine, M. S. (2023). Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. Eur Heart J, 44(4), 293–300. https://doi.org/10.1093/eurheartj/ehac577
Kato, Eri Toda, David A. Morrow, Jianping Guo, David D. Berg, Michael A. Blazing, Erin A. Bohula, Marc P. Bonaca, et al. “Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.Eur Heart J 44, no. 4 (January 21, 2023): 293–300. https://doi.org/10.1093/eurheartj/ehac577.
Kato ET, Morrow DA, Guo J, Berg DD, Blazing MA, Bohula EA, et al. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. Eur Heart J. 2023 Jan 21;44(4):293–300.
Kato, Eri Toda, et al. “Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.Eur Heart J, vol. 44, no. 4, Jan. 2023, pp. 293–300. Pubmed, doi:10.1093/eurheartj/ehac577.
Kato ET, Morrow DA, Guo J, Berg DD, Blazing MA, Bohula EA, Bonaca MP, Cannon CP, de Lemos JA, Giugliano RP, Jarolim P, Kempf T, Kristin Newby L, O’Donoghue ML, Pfeffer MA, Rifai N, Wiviott SD, Wollert KC, Braunwald E, Sabatine MS. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. Eur Heart J. 2023 Jan 21;44(4):293–300.
Journal cover image

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

January 21, 2023

Volume

44

Issue

4

Start / End Page

293 / 300

Location

England

Related Subject Headings

  • Stroke
  • Risk Factors
  • Myocardial Infarction
  • Humans
  • Heart Failure
  • Heart Disease Risk Factors
  • Growth Differentiation Factor 15
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Biomarkers